Accendra Health
230 hedge funds and large institutions have $1.13B invested in Accendra Health in 2017 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 98 increasing their positions, 66 reducing their positions, and 73 closing their positions.
48% more repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 66
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.25% less ownership
Funds ownership: 98.81% → 97.56% (-1.3%)
12% less funds holding
Funds holding: 260 → 230 (-30)
36% less capital invested
Capital invested by funds: $1.77B → $1.13B (-$639M)
37% less first-time investments, than exits
New positions opened: 46 | Existing positions closed: 73
66% less call options, than puts
Call options by funds: $1.9M | Put options by funds: $5.55M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$31.4M |
| 2 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$27.8M |
| 3 |
Morgan Stanley
New York
|
+$20.8M |
| 4 |
Two Sigma Investments
New York
|
+$18.8M |
| 5 |
O
OppenheimerFunds
New York
|
+$17M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RRAM
River Road Asset Management
Louisville,
Kentucky
|
-$37.3M |
| 2 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
-$30.9M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$30.7M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$30M |
| 5 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
-$24.7M |
ACH Hedge Fund Activity: Q4 2017 in Review
230 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Accendra Health (ACH) for Q4 2017, worth a combined $1.13B — down 36% from $1.77B a quarter earlier.
Sellers outnumbered buyers: 73 funds closed out of ACH and 46 opened new positions — a net loss of 27 holders — while 66 trimmed existing stakes and 98 added.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $31.4M. The largest seller was River Road Asset Management, exiting entirely with an estimated $37.3M sold.
- 230 institutional investors held Accendra Health (ACH) as of Q4 2017, down from 260 in Q3 2017.
- Funds reported $1.13B of Accendra Health stock for Q4 2017, down 36% quarter-over-quarter.
- 46 funds opened new Accendra Health positions in Q4 2017 and 73 closed out, a net change of -27 holders.
- The largest Accendra Health buyer in Q4 2017 was Fidelity Investments, an estimated $31.4M added.
- The largest Accendra Health seller in Q4 2017 was River Road Asset Management, an estimated $37.3M sold.
Based on aggregated 13F filings for Q4 2017.